Hydromorphone Hydrochloride
Product Images NDC 0054-0265

6 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Hydromorphone Hydrochloride (NDC 0054-0265). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hydromorph-structure-02-07-2024.jpg (Hydromorph Structure 02 07 2024)

Hydromorph-structure-02-07-2024.jpg (Hydromorph Structure 02 07 2024)
Chemical structure of Hydromorphone Hydrochloride, showing the molecular arrangement including aromatic rings, hydroxyl groups, and hydrochloride component as indicated by the HCl notation.*
FDA Label Image

Bl-1mg-ml-os-473-ml-c50000586-02-k01 (Image 01)

Bl-1mg-ml-os-473-ml-c50000586-02-k01 (Image 01)
Hydromorphone Hydrochloride 1 mg/mL oral solution label from Hikma Pharmaceuticals USA Inc. The label includes dosage strength, volume (473 mL), storage instructions, and distribution information. It prominently displays warnings and usage instructions, including habit-forming potential and shaking before use.*
FDA Label Image

Bl-4mg-100-tabs-c50000588-02-k02.jpg (Image 02)

Bl-4mg-100-tabs-c50000588-02-k02.jpg (Image 02)
Label for Hydromorphone Hydrochloride tablets, USP, 4 mg strength. The label indicates a package size of 100 tablets and includes storage instructions. The product is distributed by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ. The label features a barcode and note for prescription use only.*
FDA Label Image

Bl-8mg-100-tabs-c50000589-02-k02.jpg (Image 03)

Bl-8mg-100-tabs-c50000589-02-k02.jpg (Image 03)
Hydromorphone Hydrochloride 8 mg Tablets, USP packaging label showing 100 tablets per container. The label includes dosage information, storage instructions at 20° to 25°C, and dispensing requirements. Distributed by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ. The label clearly marks the product as Rx only and includes a barcode and NDC 0054-0265-25.*
FDA Label Image

Fc-4mg-10x10-tabs-c50000585-02-k01.jpg (Image 04)

Fc-4mg-10x10-tabs-c50000585-02-k01.jpg (Image 04)
Carton packaging label for Hydromorphone Hydrochloride Tablets, USP, 4 mg strength. The label includes the active ingredient name and strength prominently, with dosage form as tablets. The labeler is Hikma Pharmaceuticals USA Inc. The carton also features barcodes and storage instructions. This is not the 1 mg/mL strength listed in the product data.*
FDA Label Image

Blister-mat-c50000584-01-k02.jpg (Image 05)

Blister-mat-c50000584-01-k02.jpg (Image 05)
Label for Hydromorphone Hydrochloride Tablet, USP 4 mg. The label includes distribution by Hikma USA, Berkeley Heights, NJ, along with a barcode, lot number, and expiration date fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.